Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion type Assertion NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_head.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion description "[Aberrant IR-A expression may favor cancer resistance to both conventional and targeted therapies by a variety of mechanisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_provenance.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion evidence source_evidence_literature NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_provenance.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion SIO_000772 19752219 NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_provenance.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion wasDerivedFrom befree-20140225 NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_provenance.
- NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_assertion wasGeneratedBy ECO_0000203 NP816196.RAcC3S9vOpdWaYPXLclDT7VLvcJYDu2WQQqvgONOfolbI130_provenance.